You are using an older browser version. Please use a supported version for the best MSN experience.

Adagio Therapeutics CEO: We see a role in the treatment of Covid, as well as prevention

Tillman Gerngross, Adagio Therapeutics CEO, joins 'The Exchange' to discuss how his company's antibody drug was developed and its effectiveness in fighting Covid variants.

UP NEXT

UP NEXT

CNBC

image beaconimage beaconimage beacon